Literature DB >> 31439130

Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020.

Mimi C Tan1, David Y Graham1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31439130      PMCID： PMC6916726          DOI： 10.1016/j.gie.2019.05.034

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  10 in total

Review 1.  Helicobacter pylori infection is the primary cause of gastric cancer.

Authors:  D Y Graham
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

2.  The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.

Authors:  Lisette G Capelle; Annemarie C de Vries; Jelle Haringsma; Frank Ter Borg; Richard A de Vries; Marco J Bruno; Herman van Dekken; Jos Meijer; Nicole C T van Grieken; Ernst J Kuipers
Journal:  Gastrointest Endosc       Date:  2010-04-09       Impact factor: 9.427

3.  Gastritis staging in clinical practice: the OLGA staging system.

Authors:  Massimo Rugge; Alberto Meggio; Gianmaria Pennelli; Francesco Piscioli; Luciano Giacomelli; Giovanni De Pretis; David Y Graham
Journal:  Gut       Date:  2006-12-01       Impact factor: 23.059

4.  Grading of Atrophic Gastritis is Useful for Risk Stratification in Endoscopic Screening for Gastric Cancer.

Authors:  Kyosuke Kaji; Atsushi Hashiba; Chika Uotani; Yasushi Yamaguchi; Toshio Ueno; Kenji Ohno; Ichiro Takabatake; Tokio Wakabayashi; Hisashi Doyama; Itasu Ninomiya; Masato Kiriyama; Shigekazu Ohyama; Manabu Yoneshima; Nobu Koyama; Yasuo Takeda; Kenji Yasuda
Journal:  Am J Gastroenterol       Date:  2019-01       Impact factor: 10.864

5.  Effect of Helicobacter pylori eradication and high-density lipoprotein on the risk of de novo gastric cancer development.

Authors:  Su Youn Nam; Bum Joon Park; Ji Hyung Nam; Myeong-Cherl Kook
Journal:  Gastrointest Endosc       Date:  2019-04-26       Impact factor: 9.427

6.  The time to eradicate gastric cancer is now.

Authors:  D Y Graham; A Shiotani
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

7.  Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases.

Authors:  Susumu Take; Motowo Mizuno; Kuniharu Ishiki; Yasuhiro Nagahara; Tomowo Yoshida; Kenji Yokota; Keiji Oguma
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

8.  Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening.

Authors:  M Dinis-Ribeiro; G Yamaki; K Miki; A Costa-Pereira; M Matsukawa; M Kurihara
Journal:  J Med Screen       Date:  2004       Impact factor: 2.136

9.  Causal relevance of circulating high-density lipoprotein cholesterol with cancer: a Mendelian randomization meta-analysis.

Authors:  Chunhua Yang; Geng Tian; Jia Mi; Xiaodan Wei; Xuri Li; Xianglin Li; Wenming Wang; Bin Wang
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.379

10.  The diagnostic value of circulating microRNAs as a biomarker for gastric cancer: A meta‑analysis.

Authors:  Hui Wei; Ke Pu; Xiao-Guang Liu; Bo-Xuan Li; Heng-Shuo Zhang; Huan Wang; Hao Wang; Wei-Ming Sun; Yu-Ping Wang
Journal:  Oncol Rep       Date:  2018-10-11       Impact factor: 3.906
  10 in total
  6 in total

1.  Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population.

Authors:  Mimi C Tan; Quynh Ho; Theresa H Nguyen; Yan Liu; Hashem B El-Serag; Aaron P Thrift
Journal:  Dig Dis Sci       Date:  2021-11-19       Impact factor: 3.487

2.  Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori: a community-based study.

Authors:  Tsung-Hsien Chiang; Yen-Nien Chen; Yi-Ru Chen; Yu-Hua Tseng; Chun-Fu Shieh; Cheng-Ying Liu; Han-Mo Chiu; Hung Chiang; Chia-Tung Shun; Ming-Shiang Wu; Jaw-Town Lin; Yi-Chia Lee
Journal:  BMC Gastroenterol       Date:  2022-02-18       Impact factor: 3.067

3.  The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance.

Authors:  Tzu-Hsin Huang; Shih-Cheng Yang; Wei-Chen Tai; Chih-Ming Liang; Chung-Mou Kuo; Chih-Chien Yao; Cheng-Kun Wu; Yuan-Hung Kuo; Yeh-Pin Chou; Chen-Hsiang Lee; Keng-Liang Wu; Seng-Kee Chuah
Journal:  Biomed J       Date:  2020-11-24       Impact factor: 7.892

4.  Microsatellite instability/mismatch repair deficiency and activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland: A case report.

Authors:  Guang Yang
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

Review 5.  Precision Medicine Approaches to Prevent Gastric Cancer.

Authors:  Juntaro Matsuzaki; Hitoshi Tsugawa; Hidekazu Suzuki
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

6.  Metabolite Characteristics in Tongue Coating from Damp Phlegm Pattern in Patients with Gastric Precancerous Lesion.

Authors:  Yifeng Xu; Renling Zhang; Robert Morris; Feng Cheng; Yiqin Wang; Zhujing Zhu; Yiming Hao
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-02       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.